“Selection of an “acceptable” lead is probably the most important governing factor in compound claim challenges, with the potential to make or break the case.” In an earlier article, “Tips for ...

Jason Eisenberg, Olga Partington, Ph.D. Historically, obviousness of chemical compounds was assessed under the standard articulated in the Federal Circuit's 1990 decision in In re Dillon.[i] Under ...

“The public outcome of compound claim cases indicates that the success rate is much lower when compared with challenges of other types of claims.” Patent challenges are an indispensable part of the ...

Toxoplasma gondii infection is one of the most frequent parasitic infections of humans. This parasite is present in the brain of an estimated two billion people--about 40 percent of all humans on ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

In the gold rush to bring artificial intelligence to the healthcare and biopharma industries, AI has long been pitched as a way to accelerate the pace of drug development and discovery. Sometimes ...

Scientists of Far Eastern Federal University (FEFU), together with German and Russian colleagues, have developed a lead compound to fight chemotherapy-resistant prostate cancer. The original design ...

One of the most famous paintings from the Dutch Golden Age is Rembrandt van Rijn's 1642 masterpiece The Night Watch. An interdisciplinary team of researchers has conducted a fresh, in-depth analysis ...

Addressing the obviousness analysis for method of treatment claims, the US Court of Appeals for the Federal Circuit affirmed the district court’s finding of non-obviousness but rejected part of its ...

You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...